Cargando…
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
Rhino-orbital mucormycosis has seen a huge resurgence in patients post COVID-19 infection. In patients with minimal orbital disease and especially with preserved vision, retrobulbar injections of amphotericin B can be of great help in controlling the disease. Instead of giving daily injections of am...
Autores principales: | Murthy, Ramesh, Bagchi, Aadhyaa, Gote, Yogita, Desai, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917598/ https://www.ncbi.nlm.nih.gov/pubmed/34937263 http://dx.doi.org/10.4103/ijo.IJO_1511_21 |
Ejemplares similares
-
Localized surgical debridement for the management of orbital mucormycosis
por: Murthy, Ramesh, et al.
Publicado: (2022) -
Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management
por: Murthy, Ramesh, et al.
Publicado: (2021) -
Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
por: Ramamurthy, Lakshmi B, et al.
Publicado: (2022) -
Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020)